Balticpharma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 811,649 | 675,842 | 663,758 | 670,741 | 724,478 | 729,670 | 806,996 | 673,351 |
| Profit before tax | 134,158 | 75,635 | 135,807 | 94,575 | 97,160 | 74,502 | 97,019 | 28,410 |
| Net profit | 113,391 | 62,987 | 114,303 | 78,825 | 80,362 | 62,102 | 80,474 | 21,734 |
| Equity | 246,337 | 219,173 | 333,476 | 412,301 | 492,663 | 424,011 | 83,664 | 105,288 |
| Liabilities | 269,288 | 118,404 | 199,011 | 160,239 | 130,653 | 109,143 | 364,991 | 377,358 |
| Non-current assets | 3,529 | 10,139 | 13,944 | 10,722 | 7,750 | 4,957 | 2,228 | 2,335 |
| Current assets | 511,157 | 326,154 | 518,070 | 561,292 | 614,741 | 526,066 | 444,909 | 478,260 |
| Total assets | 514,686 | 336,293 | 532,014 | 572,014 | 622,491 | 531,023 | 447,137 | 480,595 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 185,480 | 237,384 | 152,812 |
| Social insurance contributions | - | - | - | - | - | 19,339 | 22,823 | 18,666 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -11.2% | -16.7% | -1.8% | +1.1% | +8.0% | +0.7% | +10.6% | -16.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 22.0% | 18.7% | 21.5% | 13.8% | 12.9% | 11.7% | 18.0% | 4.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 46.0% | 28.7% | 34.3% | 19.1% | 16.3% | 14.6% | 96.2% | 20.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.0% | 9.3% | 17.2% | 11.8% | 11.1% | 8.5% | 10.0% | 3.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 16.5% | 11.2% | 20.5% | 14.1% | 13.4% | 10.2% | 12.0% | 4.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.1 | 0.5 | 0.6 | 0.4 | 0.3 | 0.3 | 4.4 | 3.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 167,929 | 147,458 | 142,233 | 146,345 | 144,896 | 132,667 | 153,714 | 146,914 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Balticpharma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-01-16 | 2026-01-19 | 0.06 |
Balticpharma - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-03 | 2025-10-08 | 298.33 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Balticpharma, UAB (code 125126552) is a private limited liability company engaged in the wholesale of perfume and cosmetics. In the latest financial year, 2025, revenue amounted to €673.4K, which was 16.6% lower year on year and 7.7% below the 2023 level. Net profit declined to €21.7K from €80.5K in 2024 and €62.1K in 2023, and the profit margin narrowed to 3.2% from 10.0% in 2024 and 8.5% in 2023. Even so, the company remained profitable throughout the period. At the end of 2025, total assets stood at €480.6K, equity at €105.3K and liabilities at €377.4K. The equity ratio was 21.9%, debt-to-equity 3.58, asset turnover 1.40x, ROA 4.5% and ROE 20.6%. Revenue per employee was €168.3K and profit per employee €5.4K. Compared with 2024, the balance sheet expanded slightly, while profitability weakened materially.